JP6252791B2 - 脳の活動を高めるための方法および装置 - Google Patents
脳の活動を高めるための方法および装置 Download PDFInfo
- Publication number
- JP6252791B2 JP6252791B2 JP2014530377A JP2014530377A JP6252791B2 JP 6252791 B2 JP6252791 B2 JP 6252791B2 JP 2014530377 A JP2014530377 A JP 2014530377A JP 2014530377 A JP2014530377 A JP 2014530377A JP 6252791 B2 JP6252791 B2 JP 6252791B2
- Authority
- JP
- Japan
- Prior art keywords
- brain
- frequency
- instrument
- present
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title description 89
- 230000007177 brain activity Effects 0.000 title description 15
- 230000002708 enhancing effect Effects 0.000 title description 2
- 210000004556 brain Anatomy 0.000 claims description 137
- 230000000694 effects Effects 0.000 claims description 54
- 230000005672 electromagnetic field Effects 0.000 claims description 49
- 238000011282 treatment Methods 0.000 claims description 38
- 238000013528 artificial neural network Methods 0.000 claims description 22
- 238000005259 measurement Methods 0.000 claims description 14
- 230000004936 stimulating effect Effects 0.000 claims description 14
- 210000000653 nervous system Anatomy 0.000 description 64
- 230000005540 biological transmission Effects 0.000 description 52
- 210000004027 cell Anatomy 0.000 description 32
- 210000002569 neuron Anatomy 0.000 description 30
- 230000000638 stimulation Effects 0.000 description 30
- 210000004958 brain cell Anatomy 0.000 description 26
- 241000699670 Mus sp. Species 0.000 description 18
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 16
- 238000000537 electroencephalography Methods 0.000 description 16
- 208000011580 syndromic disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000005013 brain tissue Anatomy 0.000 description 14
- 210000001947 dentate gyrus Anatomy 0.000 description 14
- 201000006417 multiple sclerosis Diseases 0.000 description 14
- 230000010336 brain pathway Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 210000003128 head Anatomy 0.000 description 13
- 238000012545 processing Methods 0.000 description 13
- 210000003792 cranial nerve Anatomy 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000014674 injury Diseases 0.000 description 11
- 230000004044 response Effects 0.000 description 11
- 210000003050 axon Anatomy 0.000 description 10
- 230000001537 neural effect Effects 0.000 description 10
- 210000000225 synapse Anatomy 0.000 description 10
- 208000029028 brain injury Diseases 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 230000008733 trauma Effects 0.000 description 9
- 206010003805 Autism Diseases 0.000 description 8
- 208000020706 Autistic disease Diseases 0.000 description 8
- 208000036626 Mental retardation Diseases 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 208000012202 Pervasive developmental disease Diseases 0.000 description 8
- 208000029560 autism spectrum disease Diseases 0.000 description 8
- 206010008129 cerebral palsy Diseases 0.000 description 8
- 210000000877 corpus callosum Anatomy 0.000 description 8
- 206010015037 epilepsy Diseases 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 208000024827 Alzheimer disease Diseases 0.000 description 7
- 206010003591 Ataxia Diseases 0.000 description 7
- 206010012289 Dementia Diseases 0.000 description 7
- 208000018737 Parkinson disease Diseases 0.000 description 7
- 201000010769 Prader-Willi syndrome Diseases 0.000 description 7
- 230000002567 autonomic effect Effects 0.000 description 7
- 230000022131 cell cycle Effects 0.000 description 7
- 230000001054 cortical effect Effects 0.000 description 7
- 230000007547 defect Effects 0.000 description 7
- 208000015122 neurodegenerative disease Diseases 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 230000002490 cerebral effect Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 210000000274 microglia Anatomy 0.000 description 6
- 210000004248 oligodendroglia Anatomy 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 210000003140 lateral ventricle Anatomy 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 230000006724 microglial activation Effects 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 description 4
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 description 4
- 208000030886 Traumatic Brain injury Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000000746 body region Anatomy 0.000 description 4
- 230000003925 brain function Effects 0.000 description 4
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 description 4
- 238000002595 magnetic resonance imaging Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 210000003625 skull Anatomy 0.000 description 4
- 230000009529 traumatic brain injury Effects 0.000 description 4
- 238000004804 winding Methods 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000013529 biological neural network Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000005056 cell body Anatomy 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 230000003920 cognitive function Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000971 hippocampal effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000006756 microglial proliferation Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- 102000006386 Myelin Proteins Human genes 0.000 description 2
- 108010083674 Myelin Proteins Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 210000000133 brain stem Anatomy 0.000 description 2
- 230000006727 cell loss Effects 0.000 description 2
- 210000004720 cerebrum Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000001153 interneuron Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000005012 myelin Anatomy 0.000 description 2
- 210000003757 neuroblast Anatomy 0.000 description 2
- 230000004766 neurogenesis Effects 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 230000001936 parietal effect Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 230000003997 social interaction Effects 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 102100023413 GRB2-related adapter protein Human genes 0.000 description 1
- 101000829735 Homo sapiens GRB2-related adapter protein Proteins 0.000 description 1
- 108010083687 Ion Pumps Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 208000032369 Primary transmission Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 229950004398 broxuridine Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000009365 direct transmission Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000001661 hippocampal ca3 region Anatomy 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000005171 mammalian brain Anatomy 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000010004 neural pathway Effects 0.000 description 1
- 210000000118 neural pathway Anatomy 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000009689 neuronal regeneration Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 210000000063 presynaptic terminal Anatomy 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000003238 somatosensory effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 230000008625 synaptic signaling Effects 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
Description
(c)対象の脳波における異常な間隔を特定して分析するステップと;
(d)プロトコルを定義するステップと、(e)選択された脳神経領域に関するプロトコルを対象の神経系に送信するステップと、を含む。プロトコルを定義するステップは、代償脳波を含む電磁周波数プロフィールを作成するステップを含み;さらに、プロトコルは、共振効果を与え、これにより、新たに産生される脳細胞を、目的の病状または病変を有する脳組織領域に向かって移動させ、脳神経領域で新たな脳経路を始動させる。
図2は、社会的交流試験の結果を示している。認知機能:2ヶ月目の最後の日に、マウスの認知機能の指標としてマウスを社会認識について試験した。マウスをそれぞれ、若齢マウスに2分間対面させ、若齢マウスを調べるのに要した時間を記録した。10分後、試験したマウスを、再び若齢マウスに対面させ、再び調べる時間を測定した。同じ処置を30分後に繰り返した。2回目と3回目との社会的交流の減少は、「覚えがある」、従って興味が低いとして若齢マウスを識別するマウスの認知能力を示している。マウスと若齢マウスの最初の対面に対する2回目と3回目との社会的交流の減少は、群間で差異がないことを示している。
若年成体マウスの中程度の電磁場刺激の繰り返し曝露は、神経形成から生じる好影響をもたらすことが期待される。しかしながら、環境刺激が脳の発達過程に影響を与え得るという事実は、正常な発達の介入に弱いことが既に示されている一部の脳構造に対して起こり得る悪影響についての注意が必要である。この実施例は、このような構造の検査を示す。以下は、各構造に焦点を当てる根拠をさらに示す。
(i)対象の神経系を通る電磁場を生成するように構成された少なくとも1つの送信機、(ii)対象の脳波周波数を検出するための少なくとも1つの脳波測定装置、(iii)対象の脳波周波数の検出に関連したデータを処理するための第1のCPU、(iv)目的の活動を有する特定の脳組織への波周波数の送信に関連したデータを処理するための第2のCPU;および(v)送信機による電磁波周波数プロフィールの送信のための所定のプロトコルを含む少なくとも1つのコンピュータ可読媒体を備える、ステップと;
(b)対象の脳波における異常な間隔を特定して分析するステップと;
(c)プロトコルを定義するステップと、(d)選択された脳神経領域に関するプロトコルを対象の神経系に送信するステップと、を含み、プロトコルを定義するステップが、代償脳波を含む電磁周波数プロフィールを作成するステップを含み;さらに、このプロトコルが、共振効果を与え、これにより、新たに産生される脳細胞を、目的の病状または病変を有する脳神経領域に向かって移動させ、脳神経領域で新たな脳経路を始動させる。
Claims (8)
- 対象の脳の神経回路網を刺激するための器具であって、
前記神経回路網に関連する前記対象の脳の領域における脳波周波数を測定するように構成された脳波測定装置と、
前記対象の脳の全体積に及ぶように構成される均一な電磁場を生成するように構成された少なくとも1つの送信機であって、前記送信機は、前記均一な電磁場が、前記対象の脳の全体積に印加されるように、頭部を受容するための間隙によって分離された2つのコイルから成るヘルムホルツコイルを含む、少なくとも1つの送信機と、
測定された前記脳波周波数と等しい周波数を有する電磁場を生成させるために、所定のプロトコルに従って前記少なくとも1つの送信機を制御し、強度および期間を有する前記電磁場と前記神経回路網との間に共振効果を誘導するためのCPUと、を備える、器具。 - 前記所定のプロトコルが、複数の所定の処置プロフィールから選択される処置プロフィールである、請求項1に記載の器具。
- 前記処置プロフィールが、ローカルに保存される、請求項2に記載の器具。
- 前記処置プロフィールが、遠隔サーバーに保存される、請求項2に記載の器具。
- 前記複数の所定の処置プロフィールが、記憶装置に保存される、請求項2に記載の器具。
- 前記周波数が、0.01Hz〜100Hzの周波数範囲内である、請求項1に記載の器具。
- 前記強度が、10−6ガウス〜100ガウスの範囲である、請求項1に記載の器具。
- 前記期間が、数分から数時間の範囲である、請求項1に記載の器具。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161533917P | 2011-09-13 | 2011-09-13 | |
US61/533,917 | 2011-09-13 | ||
PCT/IL2012/000255 WO2013038400A1 (en) | 2011-09-13 | 2012-06-21 | Method and device for enhancing brain activity |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014526336A JP2014526336A (ja) | 2014-10-06 |
JP6252791B2 true JP6252791B2 (ja) | 2017-12-27 |
Family
ID=47882700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014530377A Active JP6252791B2 (ja) | 2011-09-13 | 2012-06-21 | 脳の活動を高めるための方法および装置 |
Country Status (9)
Country | Link |
---|---|
US (1) | US9694197B2 (ja) |
EP (1) | EP2755550B1 (ja) |
JP (1) | JP6252791B2 (ja) |
KR (1) | KR102001897B1 (ja) |
CN (1) | CN103917156B (ja) |
AU (1) | AU2012310074B2 (ja) |
CA (1) | CA2848549C (ja) |
HK (1) | HK1198622A1 (ja) |
WO (1) | WO2013038400A1 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013152355A1 (en) | 2012-04-06 | 2013-10-10 | Newport Brain Research Laboratory Inc. | Rtms device |
WO2015022679A1 (en) * | 2013-08-14 | 2015-02-19 | Brain Q Technologies Ltd | Regeneration of nerve fibers |
CN107205641A (zh) | 2014-08-29 | 2017-09-26 | 因赛飞公司 | 用于增强神经功能的方法和装置 |
CN105455807A (zh) * | 2014-09-03 | 2016-04-06 | 上海市精神卫生中心 | 无创的突触可塑性检测方法 |
CN106310526A (zh) * | 2015-07-10 | 2017-01-11 | 张五二 | 脑波共振仪 |
WO2017090487A1 (ja) * | 2015-11-24 | 2017-06-01 | セイコーエプソン株式会社 | 支援装置およびユーザー端末 |
US10322295B2 (en) * | 2016-09-06 | 2019-06-18 | BrainQ Technologies Ltd. | System and method for generating electromagnetic treatment protocols for the nervous system |
US10780271B2 (en) * | 2016-10-21 | 2020-09-22 | Lucas Mingzhi Zhou | System and method for perceiving smell remotely |
US11445959B2 (en) * | 2017-08-26 | 2022-09-20 | Xiaoping Li | Method and apparatus of modulating a neuronal firing frequency at a brain functional site in a brain |
WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
KR102495358B1 (ko) | 2017-09-25 | 2023-02-02 | 삼성전자주식회사 | 신경모방 자극 장치 및 그 방법 |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
CN108415567B (zh) * | 2018-02-27 | 2021-11-02 | Oppo广东移动通信有限公司 | 大脑训练方法及相关产品 |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
WO2020056418A1 (en) | 2018-09-14 | 2020-03-19 | Neuroenhancement Lab, LLC | System and method of improving sleep |
FR3089780B1 (fr) * | 2018-12-12 | 2022-07-22 | Quantum Surgical | Recalage automatique d’un bras robot pour une intervention médicale |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
CN114585414A (zh) | 2019-12-11 | 2022-06-03 | 布莱恩克科技有限公司 | 治疗设备、系统及方法 |
CN113413546A (zh) * | 2021-06-22 | 2021-09-21 | 中国科学院电工研究所 | 一种用于改善老年认知障碍的穿戴式功能磁刺激系统 |
CN116344058B (zh) * | 2023-05-29 | 2023-08-18 | 之江实验室 | 一种基于图信号的阿尔兹海默风险标注方法及装置 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2477488A1 (en) * | 2002-02-04 | 2003-08-14 | Great Lake Biosciences, Llc | Treatment of neurological disorders using electrical stimulation |
WO2003098268A1 (en) * | 2002-05-17 | 2003-11-27 | Musc Foundation For Research Development | Method, apparatus, and system for automatically positioning a probe or sensor |
CN1234430C (zh) * | 2003-05-08 | 2006-01-04 | 何诺 | 超反射脑磁治疗仪 |
CN1879906A (zh) * | 2005-06-15 | 2006-12-20 | 郑云峰 | 中枢神经系统磁刺激装置及其使用方法 |
US9037247B2 (en) | 2005-11-10 | 2015-05-19 | ElectroCore, LLC | Non-invasive treatment of bronchial constriction |
WO2008070001A2 (en) * | 2006-12-01 | 2008-06-12 | Beth Israel Deaconess Medical Center, Inc. | Transcranial magnetic stimulation (tms) methods and apparatus |
US8449441B2 (en) * | 2008-07-16 | 2013-05-28 | Frank Sivo | Methods to arrest cancer cell growth and proliferation using electromagnetic energy delivered via electromagnetic coil systems |
AU2010315132A1 (en) * | 2009-11-04 | 2012-05-31 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Devices and methods for modulating brain activity |
US8585568B2 (en) * | 2009-11-12 | 2013-11-19 | Neosync, Inc. | Systems and methods for neuro-EEG synchronization therapy |
WO2011079309A2 (en) * | 2009-12-23 | 2011-06-30 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
-
2012
- 2012-06-21 EP EP12831890.4A patent/EP2755550B1/en active Active
- 2012-06-21 CA CA2848549A patent/CA2848549C/en active Active
- 2012-06-21 KR KR1020147009865A patent/KR102001897B1/ko active IP Right Grant
- 2012-06-21 WO PCT/IL2012/000255 patent/WO2013038400A1/en active Application Filing
- 2012-06-21 JP JP2014530377A patent/JP6252791B2/ja active Active
- 2012-06-21 CN CN201280055647.3A patent/CN103917156B/zh active Active
- 2012-06-21 AU AU2012310074A patent/AU2012310074B2/en active Active
- 2012-06-21 US US14/344,606 patent/US9694197B2/en active Active
-
2014
- 2014-12-01 HK HK14112089.1A patent/HK1198622A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2012310074A1 (en) | 2014-04-10 |
US9694197B2 (en) | 2017-07-04 |
HK1198622A1 (en) | 2015-05-22 |
EP2755550A4 (en) | 2015-04-15 |
KR20140068191A (ko) | 2014-06-05 |
EP2755550B1 (en) | 2019-06-05 |
CA2848549C (en) | 2019-09-10 |
JP2014526336A (ja) | 2014-10-06 |
KR102001897B1 (ko) | 2019-07-19 |
CN103917156A (zh) | 2014-07-09 |
US20150018706A1 (en) | 2015-01-15 |
AU2012310074B2 (en) | 2017-04-20 |
EP2755550A1 (en) | 2014-07-23 |
CA2848549A1 (en) | 2013-03-21 |
WO2013038400A1 (en) | 2013-03-21 |
CN103917156B (zh) | 2016-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6252791B2 (ja) | 脳の活動を高めるための方法および装置 | |
US11672466B2 (en) | System and method for modeling brain dynamics in normal and diseased states | |
Lefaucheur | Transcranial magnetic stimulation | |
Jannati et al. | Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation | |
Huang et al. | Plasticity induced by non-invasive transcranial brain stimulation: a position paper | |
Liu et al. | Frequency-selective control of cortical and subcortical networks by central thalamus | |
Zhang et al. | A prototype closed-loop brain–machine interface for the study and treatment of pain | |
Pashut et al. | Patch-clamp recordings of rat neurons from acute brain slices of the somatosensory cortex during magnetic stimulation | |
Shulman et al. | Final common pathway for tinnitus: theoretical and clinical implications of neuroanatomical substrates. | |
Farzan | Single-pulse transcranial magnetic stimulation (TMS) protocols and outcome measures | |
Michmizos et al. | Prediction of the timing and the rhythm of the parkinsonian subthalamic nucleus neural spikes using the local field potentials | |
US20160184599A1 (en) | Regeneration of nerve fibers | |
Mittal et al. | Effect of neuroanatomy on corticomotor excitability during and after transcranial magnetic stimulation and intermittent theta burst stimulation | |
Cattaneo | Transcranial magnetic stimulation | |
Wang et al. | Functional MRI reveals brain-wide actions of thalamically-initiated oscillatory activities on associative memory consolidation | |
Noh | Exploring cortical plasticity and oscillatory brain dynamics via transcranial magnetic stimulation and resting-state electroencephalogram | |
Liu et al. | Association Between Responsiveness to Transcranial Magnetic Stimulation and Interhemispheric Functional Connectivity of Sensorimotor Cortex in Older Adults | |
US11896833B2 (en) | Generating voltage-gradient geometries in biological tissue | |
de Graaf et al. | The various forms of non-invasive brain stimulation and their clinical relevance | |
Ezzyat et al. | Brain Stimulation | |
Mittal | Intermittent Theta Burst Stimulation: Application to Spinal Cord Injury Rehabilitation and Computational Modeling | |
Salo | Probing brain connectivity with transcranial magnetic stimulation | |
Dörre | EEG-triggered TMS of dorsomedial prefrontal cortex selectively modulates working memory performance depending on the phase of endogenous theta oscillation | |
WO2024006939A2 (en) | Systems and methods to characterize individual response to brain perturbation in patients with alzheimer's disease | |
Masina | Behavioral and neurophysiological modulation of error-related processes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140513 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150622 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150828 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160520 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160531 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160826 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160927 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170307 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170703 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170719 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20170822 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171017 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171114 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6252791 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |